EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Sacubitril/Valsartan Ameliorates Inflammation and Oxidative Stress in Hypertensive Heart Disease by Upregulating CAMKK2 Protein and Modulating the AMPK / AKT / GSK ‐3β Axis

Yan-Jun Yang iD, Jiu-Sheng Li

The Kaohsiung Journal of Medical Sciences · 2026

DOI: 10.1002/kjm2.70127 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Kaohsiung Journal of Medical Sciences, 2026. Verfasst von Yan-Jun Yang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Practice, Tiyuzhongxin Street Community Health Service Center in Nankai District of Tianjin, Tianjin, China. Hauptthemen laut MEDLINE: Oxidative Stress, Calcium-Calmodulin-Dependent Protein Kinase Kinase, Glycogen Synthase Kinase 3 beta, AMP-Activated Protein Kinases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sacubitril/valsartan (Sac/Val) has emerged as an effective compound with myocardium‐protective functions in experimental and clinical trials for heart failure. This study investigated the function of Sac/Val in hypertensive heart disease (HHD) and explored the underlying mechanism. Spontaneous hypertensive rats (SHRs) were used as an animal model of HHD. Sac/Val administration ameliorated pathological injury, fibrosis, cell apoptosis, inflammatory cytokine production, and oxidative stress in the myocardial tissues of HHD rats. Similar findings were observed in vitro, where Sac/Val treatment reduced inflammation, oxidative stress, and fibrosis‐related markers in Ang II‐challenged H9C2 cells. Calcium/calmodulin‐dependent protein kinase kinase 2 (CAMKK2) was identified as a target of Sac/Val which was downregulated in HHD models, and CAMKK2 protein levels were restored by Sac/Val treatment. Lentiviral vector‐induced CAMKK2 knockdown reduced the phosphorylation levels of AMPKα, AKT, and GSK‐3β, thereby negating the treatment effects of Sac/Val. Further treatment with AICAR, an AMPK agonist, significantly reactivated the AMPK/AKT/GSK‐3β cascade and alleviated inflammatory injury in both models. Collectively, this study suggests that Sac/Val ameliorates inflammation and oxidative stress in HHD by restoring the CAMKK2 protein and activating the AMPK/AKT/GSK‐3β cascade.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Oxidative StressCalcium-Calmodulin-Dependent Protein Kinase KinaseGlycogen Synthase Kinase 3 betaAMP-Activated Protein KinasesValsartanAminobutyratesBiphenyl CompoundsHypertensionHeart DiseasesAnimalsRatsProto-Oncogene Proteins c-aktMaleDrug CombinationsRats, Inbred SHRInflammationSignal TransductionDisease Models, AnimalUp-RegulationMyocardiumCell LineApoptosis

Stichwörter der Autor:innen

CAMKK2hypertensive heart diseaseinflammationoxidative stresssacubitril/valsartan

Substanzen

Calcium-Calmodulin-Dependent Protein Kinase Kinasesacubitril and valsartan sodium hydrate drug combinationGlycogen Synthase Kinase 3 betaProto-Oncogene Proteins c-aktAMP-Activated Protein KinasesValsartanAminobutyratesBiphenyl CompoundsDrug Combinations

Autor:innen und Institutionen

  • Department of General Practice, Tiyuzhongxin Street Community Health Service Center in Nankai District of Tianjin, Tianjin, China.
  • Department of Internal Medicine, Tianjin Shuige Hospital, Tianjin, China.

ORCID-Profile: Yan-Jun Yang

Zitieren

APA

Yang, Y. J., & Li, J. S. (2026). Sacubitril/Valsartan Ameliorates Inflammation and Oxidative Stress in Hypertensive Heart Disease by Upregulating CAMKK2 Protein and Modulating the AMPK / AKT / GSK ‐3β Axis. The Kaohsiung Journal of Medical Sciences. https://doi.org/10.1002/kjm2.70127

Vancouver

Yang YJ, Li JS. Sacubitril/Valsartan Ameliorates Inflammation and Oxidative Stress in Hypertensive Heart Disease by Upregulating CAMKK2 Protein and Modulating the AMPK / AKT / GSK ‐3β Axis. The Kaohsiung Journal of Medical Sciences. 2026. doi:10.1002/kjm2.70127

BibTeX
@article{Yang2026,
  author = {Yang, Yan-Jun and Li, Jiu-Sheng},
  title = {Sacubitril/Valsartan Ameliorates Inflammation and Oxidative Stress in Hypertensive Heart Disease by Upregulating CAMKK2 Protein and Modulating the AMPK / AKT / GSK ‐3β Axis},
  journal = {The Kaohsiung Journal of Medical Sciences},
  year = {2026},
  doi = {10.1002/kjm2.70127}
}
Kostenlos starten →